Celldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance Report
Summary
Celldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.
Key Highlights
Celldex Therapeutics Celldex or 'the company' is a biopharmaceutical company engaged in the development of immunotherapy technologies for cancer and other diseases. The company operates in the US. It is headquartered in Hampton, New Jersey, and employed 199 people of which 196 were fulltime employees 1 part time and 2 interns as on December 31, 2015.
Scope
Detailed information on Celldex Therapeutics, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Celldex Therapeutics, Inc. in the form of a SWOT analysis
An indepth view of the business model of Celldex Therapeutics, Inc. including a breakdown and examination of key business segments
Intelligence on Celldex Therapeutics, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Celldex Therapeutics, Inc., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Celldex Therapeutics, Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Celldex Therapeutics, Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Celldex Therapeutics, Inc.'s business structure, strategy and prospects.